At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 66 enrolled
Drug / intervention
ondansetron +2 moredrug
Likely dose
ondansetron 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Antagonism Research Between Antiemetics Agents (Droperidol, Dexametasone, Ondansetron) and Acetaminophen in Thyroidectomy's Post-operative Analgesia.
In Brief
A Phase 3 clinical trial evaluating ondansetron, Droperidol, and 1 other intervention for Interaction Between Antiemetic Drugs and Paracetamol. Completed, enrolled 66 participants across 1 site.
Detailed Summary
The purpose of our study is to determine if there is an antagonism between drugs used in the prevention of postoperative nausea and vomiting (PONV) on the analgesia led by acetaminophen after thyroidectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
Primary CompletionJan 2011
Study CompletionJun 2011
First PostedSep 2012
TodayJul 2026
First PostedSep 5, 2012
Enrollment StartJun 1, 2009
Primary CompletionJan 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 13.8 years ago
Interventions
ondansetrondrug
ondansetron: 4 mg intravenous administration afer the induction of anesthesia.
Droperidoldrug
droperidol: 1.25 mg intravenous administration after the induction of anesthesia.
Dexamethasonedrug
dexametasone: 4 mg intravenous administration after the induction of anesthesia.